Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis

Authors: Peng Bai, Yongchang Sun, Jianmin Jin, Jia Hou, Ran Li, Qing Zhang, Yang Wang

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

Osteoporosis is one of the systemic features of COPD. A correlation between the emphysema phenotype of COPD and reduced bone mineral density (BMD) is suggested by some studies, however, the mechanisms underlying this relationship are unclear. Experimental studies indicate that IL-1β, IL-6 and TNF-α may play important roles in the etiology of both osteoporosis and emphysema. The OPG/RANK/RANKL system is an important regulator of bone metabolism, and participates in the development of post-menopausal osteoporosis. Whether the OPG/RANK/RANKL pathway is involved in the pathogenesis of osteoporosis in COPD has not been studied.

Methods

Eighty male patients (current or former smokers) completed a chest CT scan, pulmonary function test, dual x-ray absorptiometry measurements and questionnaires. Among these subjects, thirty patients with normal BMD and thirty patients with low BMD were selected randomly for measurement of IL-1β, IL-6, TNF-α (flow cytometry) and OPG/RANK/RANKL (ELISA). Twenty age-matched healthy volunteers were recruited as controls.

Results

Among these eighty patients, thirty-six had normal BMD and forty-four had low BMD. Age, BMI and CAT score showed significant differences between these two COPD groups (p < 0.05). The low-attenuation area (LAA%) in the lungs of COPD patients was negatively correlated with lumbar vertebral BMD (r = 0.741; p < 0.0001). Forward logistic regression analysis showed that only LAA% (p = 0.005) and BMI (p = 0.009) were selected as explanatory variables. The level of IL-1β was significantly higher in the COPD patients as compared to the normal controls (p < 0.05), but the difference between the two COPD groups did not reach significance. The levels of IL-6 and TNF-α among the three groups were significantly different (p < 0.05). The level of RANKL and the RANKL/OPG ratio were significantly higher in COPD patients with low BMD compared to those with normal BMD and the normal controls (p < 0.05), and correlated negatively with lumbar vertebral BMD, but positively with LAA%.

Conclusions

Radiographic emphysema is correlated with low BMD in current and former smokers with COPD. IL-1β, IL-6, TNF-α, and the osteoporosis-related protein system OPG/RANK/RANKL may have some synergetic effects on emphysema and bone loss in COPD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006, 27: 397-412. 10.1183/09031936.06.00025805.CrossRefPubMed Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006, 27: 397-412. 10.1183/09031936.06.00025805.CrossRefPubMed
2.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555. 10.1164/rccm.200703-456SO.CrossRefPubMed Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Van Weel C, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Am J Respir Crit Care Med. 2007, 176: 532-555. 10.1164/rccm.200703-456SO.CrossRefPubMed
3.
go back to reference Agusti AG, Soriano JB: COPD as a systemic disease. COPD. 2008, 5: 133-138. 10.1080/15412550801941349.CrossRefPubMed Agusti AG, Soriano JB: COPD as a systemic disease. COPD. 2008, 5: 133-138. 10.1080/15412550801941349.CrossRefPubMed
4.
go back to reference National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. 2003, Washington, DC. National Osteoporosis Foundation National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. 2003, Washington, DC. National Osteoporosis Foundation
5.
go back to reference Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003, 21: 347-360. 10.1183/09031936.03.00405703.CrossRefPubMed Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X: Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003, 21: 347-360. 10.1183/09031936.03.00405703.CrossRefPubMed
6.
go back to reference Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Mark S: Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest. 1999, 116: 1616-1624. 10.1378/chest.116.6.1616.CrossRefPubMed Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Mark S: Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest. 1999, 116: 1616-1624. 10.1378/chest.116.6.1616.CrossRefPubMed
7.
go back to reference Katsura H, Kida K: A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002, 122: 1949-1955. 10.1378/chest.122.6.1949.CrossRefPubMed Katsura H, Kida K: A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002, 122: 1949-1955. 10.1378/chest.122.6.1949.CrossRefPubMed
8.
go back to reference Kjensli A, Mowinckel P, Ryg MS, Falch JA: Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007, 40: 493-497. 10.1016/j.bone.2006.09.005.CrossRefPubMed Kjensli A, Mowinckel P, Ryg MS, Falch JA: Low bone mineral density is related to severity of chronic obstructive pulmonary disease. Bone. 2007, 40: 493-497. 10.1016/j.bone.2006.09.005.CrossRefPubMed
9.
go back to reference Vrieze A, de Greef MH, Wy'kstra PJ, Wempe JB: Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007, 18: 1197-1202. 10.1007/s00198-007-0355-7.CrossRefPubMed Vrieze A, de Greef MH, Wy'kstra PJ, Wempe JB: Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass. Osteoporos Int. 2007, 18: 1197-1202. 10.1007/s00198-007-0355-7.CrossRefPubMed
10.
go back to reference Mineo TC, Ambrogi V, Mineo D, Fabbri A, Fabbrini E, Massoud R: Bone mineral density improvement after lung volume reduction surgery for severe emphysema. Chest. 2005, 127: 1960-1966. 10.1378/chest.127.6.1960.CrossRefPubMed Mineo TC, Ambrogi V, Mineo D, Fabbri A, Fabbrini E, Massoud R: Bone mineral density improvement after lung volume reduction surgery for severe emphysema. Chest. 2005, 127: 1960-1966. 10.1378/chest.127.6.1960.CrossRefPubMed
11.
go back to reference Blake GM, Knapp KM, Fogelman I: Dual X-ray absorptiometry-clinical evaluation of a new cone-beam system. Calcif Tissue Int. 2005, 76: 113-120. 10.1007/s00223-004-0080-6.CrossRefPubMed Blake GM, Knapp KM, Fogelman I: Dual X-ray absorptiometry-clinical evaluation of a new cone-beam system. Calcif Tissue Int. 2005, 76: 113-120. 10.1007/s00223-004-0080-6.CrossRefPubMed
12.
go back to reference Madani A, Zanen J, de Maertelaer V, Gevenois PA: Pulmonary emphysema: objective quantification at multi-detector row CT; comparison with macroscopic and microscopic morphometry. Radiology. 2006, 238: 1036-1043. 10.1148/radiol.2382042196.CrossRefPubMed Madani A, Zanen J, de Maertelaer V, Gevenois PA: Pulmonary emphysema: objective quantification at multi-detector row CT; comparison with macroscopic and microscopic morphometry. Radiology. 2006, 238: 1036-1043. 10.1148/radiol.2382042196.CrossRefPubMed
13.
go back to reference Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J, EPI-SCAN Steering Committee: Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respiratory Research. 2010, 11: 63-CrossRefPubMedPubMedCentral Garcia-Rio F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J, EPI-SCAN Steering Committee: Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respiratory Research. 2010, 11: 63-CrossRefPubMedPubMedCentral
14.
go back to reference Barnes PJ, Celli BR: Systemic manifestation and comorbidities of COPD. Eur Respir J. 2009, 33: 1165-1185. 10.1183/09031936.00128008.CrossRefPubMed Barnes PJ, Celli BR: Systemic manifestation and comorbidities of COPD. Eur Respir J. 2009, 33: 1165-1185. 10.1183/09031936.00128008.CrossRefPubMed
15.
go back to reference Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA: Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006, 173: 71-78. 10.1164/rccm.200505-704OC.CrossRefPubMed Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA: Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006, 173: 71-78. 10.1164/rccm.200505-704OC.CrossRefPubMed
16.
go back to reference Gregory R, Mundy MD: Osteoporosis and Inflammation. Nutrition Reviews. 2007, 65: S147-S151. 10.1301/nr.2007.dec.S147-S151.CrossRef Gregory R, Mundy MD: Osteoporosis and Inflammation. Nutrition Reviews. 2007, 65: S147-S151. 10.1301/nr.2007.dec.S147-S151.CrossRef
17.
go back to reference McLean RR: Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep. 2009, 7: 134-139. 10.1007/s11914-009-0023-2.CrossRefPubMed McLean RR: Proinflammatory cytokines and osteoporosis. Curr Osteoporos Rep. 2009, 7: 134-139. 10.1007/s11914-009-0023-2.CrossRefPubMed
18.
go back to reference Kwan TS, Padrines M, Théoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016/j.cytogfr.2003.10.005.CrossRef Kwan TS, Padrines M, Théoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016/j.cytogfr.2003.10.005.CrossRef
19.
go back to reference Théoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004, 15: 457-475. 10.1016/j.cytogfr.2004.06.004.CrossRefPubMed Théoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D: The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004, 15: 457-475. 10.1016/j.cytogfr.2004.06.004.CrossRefPubMed
20.
go back to reference Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CH, Zhang Y, Leader JK, Gur D, Greenspan SL, Sciurba FC: Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort. Am J Respir Crit Care Med. 2011, 183: 885-890. 10.1164/rccm.201004-0666OC.CrossRefPubMed Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang CH, Zhang Y, Leader JK, Gur D, Greenspan SL, Sciurba FC: Radiographic Emphysema Predicts Low Bone Mineral Density in a Tobacco-exposed Cohort. Am J Respir Crit Care Med. 2011, 183: 885-890. 10.1164/rccm.201004-0666OC.CrossRefPubMed
21.
go back to reference American Thoracic Society: Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis. 1982, 126: 952-956. American Thoracic Society: Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis. 1982, 126: 952-956.
22.
go back to reference ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six minute walk test. Am J Respir Crit Care Med. 2002, 116: 111-117. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six minute walk test. Am J Respir Crit Care Med. 2002, 116: 111-117.
23.
go back to reference Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Plata P: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.CrossRefPubMed Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Plata P: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350: 1005-1012. 10.1056/NEJMoa021322.CrossRefPubMed
24.
go back to reference Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.CrossRefPubMed Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.CrossRefPubMed
25.
go back to reference Lee TA, Weiss KB: Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 169: 855-859. 10.1164/rccm.200307-926OC.CrossRefPubMed Lee TA, Weiss KB: Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 169: 855-859. 10.1164/rccm.200307-926OC.CrossRefPubMed
26.
go back to reference Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, Nixon LS, Evans WD, Griffiths TL, Shale DJ: Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 170: 1286-1293. 10.1164/rccm.200406-754OC.CrossRefPubMed Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, Nixon LS, Evans WD, Griffiths TL, Shale DJ: Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004, 170: 1286-1293. 10.1164/rccm.200406-754OC.CrossRefPubMed
27.
go back to reference Duckers JM, Evans BA, Fraser WD, Stone MD, Bolton CE, Shale DJ: Low bone mineral density in men with chronic obstructive pulmonary disease. Respiratory Research. 2011, 12: 101-10.1186/1465-9921-12-101.CrossRefPubMedPubMedCentral Duckers JM, Evans BA, Fraser WD, Stone MD, Bolton CE, Shale DJ: Low bone mineral density in men with chronic obstructive pulmonary disease. Respiratory Research. 2011, 12: 101-10.1186/1465-9921-12-101.CrossRefPubMedPubMedCentral
28.
go back to reference Ohara T, Hirai T, Muro S, Haruna A, Terada K, Kinose D, Marumo S, Ogawa E, Hoshino Y, Niimi A, Chin K, Mishima M: Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest. 2008, 134: 1244-1249. 10.1378/chest.07-3054.CrossRefPubMed Ohara T, Hirai T, Muro S, Haruna A, Terada K, Kinose D, Marumo S, Ogawa E, Hoshino Y, Niimi A, Chin K, Mishima M: Relationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPD. Chest. 2008, 134: 1244-1249. 10.1378/chest.07-3054.CrossRefPubMed
29.
go back to reference Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, Kondragunta V, Lee JS, Zhang Y, Choi AMK, Lokshin AE, Kaminski N, Gur D, Sciurba FC: The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS ONE. 4 (8): e6865- Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, Kondragunta V, Lee JS, Zhang Y, Choi AMK, Lokshin AE, Kaminski N, Gur D, Sciurba FC: The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS ONE. 4 (8): e6865-
30.
go back to reference Ragab AA, Nalepka JL, Bi Y, Greenfield EM: Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol. 2002, 283: C679-687.CrossRefPubMed Ragab AA, Nalepka JL, Bi Y, Greenfield EM: Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells. Am J Physiol Cell Physiol. 2002, 283: C679-687.CrossRefPubMed
31.
go back to reference Horowitz MC, Xi Y, Wilson K, Kacena MA: Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 2001, 12: 9-18. 10.1016/S1359-6101(00)00030-7.CrossRefPubMed Horowitz MC, Xi Y, Wilson K, Kacena MA: Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev. 2001, 12: 9-18. 10.1016/S1359-6101(00)00030-7.CrossRefPubMed
32.
go back to reference Fouque-Aubert A, Chapurlat R: Influence of RANKL inhibition on immune system in the treatment of bone diseases. Joint Bone Spine. 2008, 75: 5-10. 10.1016/j.jbspin.2007.05.004.CrossRefPubMed Fouque-Aubert A, Chapurlat R: Influence of RANKL inhibition on immune system in the treatment of bone diseases. Joint Bone Spine. 2008, 75: 5-10. 10.1016/j.jbspin.2007.05.004.CrossRefPubMed
33.
go back to reference Simonet WS, Lacey DL, Dunstan CR, Kelley MC, Hang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, RenshawGegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997, 89: 309-319. 10.1016/S0092-8674(00)80209-3.CrossRefPubMed Simonet WS, Lacey DL, Dunstan CR, Kelley MC, Hang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, RenshawGegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997, 89: 309-319. 10.1016/S0092-8674(00)80209-3.CrossRefPubMed
34.
go back to reference Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016/S0092-8674(00)81569-X.CrossRefPubMed Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176. 10.1016/S0092-8674(00)81569-X.CrossRefPubMed
35.
go back to reference Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001, 142: 5050-5055. 10.1210/en.142.12.5050.CrossRefPubMed Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001, 142: 5050-5055. 10.1210/en.142.12.5050.CrossRefPubMed
36.
go back to reference Eagan T, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Dams JK, Aukrust P, Bakke PS: Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010, 35: 540-548. 10.1183/09031936.00088209.CrossRefPubMed Eagan T, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Dams JK, Aukrust P, Bakke PS: Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010, 35: 540-548. 10.1183/09031936.00088209.CrossRefPubMed
Metadata
Title
Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
Authors
Peng Bai
Yongchang Sun
Jianmin Jin
Jia Hou
Ran Li
Qing Zhang
Yang Wang
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-157

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue